Suppr超能文献

亨廷顿病小鼠模型中γ-氨基丁酸药理学药物的行为反应改变。

Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.

机构信息

Ph.D. Program for Translational Medicine, China Medical University and Academia Sinica, Taiwan.

Department of Neurology, China Medical University Hospital, Taichung, Taiwan.

出版信息

Mov Disord. 2017 Nov;32(11):1600-1609. doi: 10.1002/mds.27107. Epub 2017 Aug 7.

Abstract

BACKGROUND

Disruptions in gamma-aminobutyric (GABA) acid signaling are believed to be involved in Huntington's disease pathogenesis, but the regulation of GABAergic signaling remains elusive. Here we evaluated GABAergic signaling by examining the function of GABAergic drugs in Huntington's disease and the expression of GABAergic molecules using mouse models and human brain tissues from Huntington's disease.

METHODS

We treated wild-type and R6/2 mice (a transgenic Huntington's disease mouse model) acutely with vehicle, diazepam, or gaboxadol (drugs that selectively target synaptic or extrasynaptic GABA receptors) and monitored their locomotor activity. The expression levels of GABA receptors and a major neuron-specific chloride extruder (potassium-chloride cotransporter-2) were analyzed by real-time quantitative polymerase chain reaction, Western blot, and immunocytochemistry.

RESULTS

The R6/2 mice were less sensitive to the sedative effects of both drugs, suggesting reduced function of GABA receptors. Consistently, the expression levels of α1/α2 and δ subunits were lower in the cortex and striatum of R6/2 mice. Similar results were also found in 2 other mouse models of Huntington's disease and in Huntington's disease patients. Moreover, the interaction and expression levels of potassium-chloride cotransporter-2 and its activator (brain-type creatine kinase) were decreased in Huntington's disease neurons. These findings collectively suggest impaired chloride homeostasis, which further dampens GABA receptor-mediated inhibitory signaling in Huntington's disease brains.

CONCLUSIONS

The dysregulated GABAergic responses and altered expression levels of GABA receptors and potassium-chloride cotransporter-2 in Huntington's disease mice appear to be authentic and may contribute to the clinical manifestations of Huntington's disease patients. © 2017 International Parkinson and Movement Disorder Society.

摘要

背景

据信,γ-氨基丁酸(GABA)酸信号的中断与亨廷顿病的发病机制有关,但 GABA 能信号的调节仍不清楚。在这里,我们通过检查亨廷顿病中 GABA 能药物的功能以及使用小鼠模型和亨廷顿病患者的人脑组织来评估 GABA 能信号。

方法

我们用载体、地西泮或加巴喷丁(选择性靶向突触或 extrasynaptic GABA 受体的药物)急性处理野生型和 R6/2 小鼠(亨廷顿病转基因小鼠模型),并监测其运动活动。通过实时定量聚合酶链反应、Western blot 和免疫细胞化学分析 GABA 受体和主要神经元特异性氯离子外排体(钾氯离子共转运蛋白-2)的表达水平。

结果

R6/2 小鼠对两种药物的镇静作用的敏感性降低,表明 GABA 受体功能降低。一致地,R6/2 小鼠皮质和纹状体中α1/α2 和δ亚基的表达水平较低。在另外 2 种亨廷顿病小鼠模型和亨廷顿病患者中也发现了类似的结果。此外,钾氯离子共转运蛋白-2及其激活剂(脑型肌酸激酶)的相互作用和表达水平在亨廷顿病神经元中降低。这些发现共同表明氯离子稳态受损,进一步抑制亨廷顿病大脑中 GABA 受体介导的抑制性信号。

结论

亨廷顿病小鼠中 GABA 能反应的失调以及 GABA 受体和钾氯离子共转运蛋白-2的表达水平改变似乎是真实的,可能导致亨廷顿病患者的临床表现。国际帕金森和运动障碍学会 2017 年。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验